A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA)
Open accessThe DOI matches its Crossref record.
Abstract
Aim: To conduct an open‐label study to provide UK real‐world evidence regarding the use of insulin glargine 300 units/ml (U300) in people with Type 1 diabetes mellitus. Methods: People with Type 1 diabetes who had been prescribed U300 ≥6 months before data collection and had HbA 1c levels recorded within 3 months prior to U300 (baseline) were included. The primary endpoint was change in HbA 1c from baseline to month 6 after U300 initiation. Other endpoints included number of documented hypoglycaemic and diabetic ketoacidosis episodes, and change in daily basal insulin dose. Results: A total of 298 people with Type 1 diabetes were included [mean age 42.1 years, mean HbA 1c 79 mmol/mol (9.4%)]. After U300 initiation, the mean reduction in HbA 1c from baseline to month 6 was –4 mmol/mol (–0.4%; P<0.001; n=188). The total daily basal insulin dose at 6 months was 1.3 units higher than at the time of U300 initiation (P<0.001; n=275) but was not significantly different from the prior basal insulin dose. There was no clinically significant difference in weight between baseline and month 6 [mean difference +0.7 kg, 95% CI –0.1, 1.5; P=0.084; n=115). During the 6 months before and after U300 initiation, severe hypoglycaemic episodes were documented for 6/298 and 4/298 participants. Diabetic ketoacidosis episodes requiring Accident and Emergency department visits or hospitalization were documented for 4/298 and 6/298 participants, before and after U300 initiation, respectively. Conclusions: In people with Type 1 diabetes, a change in basal insulin to U300 was associated with clinically and statistically significant HbA 1c improvements, without significant changes in basal insulin dose and weight. Documented severe hypoglycaemia episodes and diabetic ketoacidosis requiring Accident and Emergency department visits or hospitalization were low and similar before and after U300 initiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment strategies against diabetes: Success so far and challenges ahead.
Khursheed, R., Singh, S. K., Wadhwa, S., Kapoor, B., Gulati, M., Kumar, R., Ramanunny, A. K., Awasthi, A., & Dua, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172625 · Cited by 239
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
Janež, A., Guja, C., Mitrakou, A., Lalic, N., Tankova, T., Czupryniak, L., Tabák, A. G., Prazny, M., Martinka, E., & Smircic-Duvnjak, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00743-7 · Cited by 177
Concentrated insulins: Clinical update of therapeutic options
Umpierrez, G. E., Holt, E. H., Einhorn, D., & McGill, J. B. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0607 · Cited by 44
Danne, T., Matsuhisa, M., Sussebach, C., Goyeau, H., Lauand, F., Niemoeller, E., & Bolli, G. B. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14109 · Cited by 25
Literature Review: Drug and Alcohol-Induced Hypoglycaemia
Kalaria, T., Ko, Y. L., & Issuree, K. K. J. (2021) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm-21-16 · Cited by 17
“The newer 300 U/mL glargine insulin has been shown to achieve HbA1c reduction despite no change in hypoglycaemia frequency or weight gain in type 1 diabetes and may reduce nocturnal hypoglycaemia compared to 100 U/mL glargine insulin (24,25).”
Background
Metadata
- Authors
- Pang, T., Bain, S. C., Black, R. N. A., Boyle, J. G., Elliott, J., Holcombe, A., Lee, K. C. S., Mulligan, C., Saunders, L., Yousseif, A., & Baxter, M.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2018-11-16
- Volume
- 36
- Issue
- 1
- Pages
- 110-119
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2898383408
- Cited by
- 21
- References
- 0
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA). https://app.cochat.ai/papers/10.1111/dme.13847
- The paper
- Pang, T., Bain, S. C., Black, R. N. A., Boyle, J. G., Elliott, J., Holcombe, A., Lee, K. C. S., Mulligan, C., Saunders, L., Yousseif, A., & Baxter, M. (2019). A multicentre, UK, retrospective, observational study to assess the effectiveness of insulin glargine 300 units/ml in treating people with Type 1 diabetes mellitus in routine clinical practice (SPARTA). Diabetic Medicine. https://doi.org/10.1111/dme.13847
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.